CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation

CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future cardiology 2021-08, Vol.17 (5), p.855-864
Hauptverfasser: Besford, Megan, Leahy, Thomas P, Sammon, Cormac, Ulvestad, Maria, Carroll, Robert, Mehmud, Faisal, Alikhan, Raza, Ramagopalan, Sreeram
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 864
container_issue 5
container_start_page 855
container_title Future cardiology
container_volume 17
creator Besford, Megan
Leahy, Thomas P
Sammon, Cormac
Ulvestad, Maria
Carroll, Robert
Mehmud, Faisal
Alikhan, Raza
Ramagopalan, Sreeram
description
doi_str_mv 10.2217/fca-2020-0175
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_2217_fca_2020_0175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2217_fca_2020_0175</sourcerecordid><originalsourceid>FETCH-LOGICAL-c152t-e103827c1340ca2c5ceb9407bf6018f5a78a633202260f0996af0b680240c3e63</originalsourceid><addsrcrecordid>eNotkE1LxDAQhoMouK4evecPRCdJm49j3Q8rLKxY9VrSbLpEYytJRf33ZtXLzPDOw8A8CF1SuGKMyuveGsKAAQEqyyM0o7IoiGJaHee5kJoIIdUpOkvpBYBLTfUMfS3qCjO8bHIhz1VjsRl2uK4acrNZLfGDT6-4sWN06XcRnQnkc4xhh7fRBFwNk7ej2X8EM0z4PmM2-s4Pe7x01ic_Dgn7AVdT9Jle-y76EMyU83N00puQ3MV_n6On9epxUZPN9vZuUW2IpSWbiKPAFZOW8gKsYba0rtMFyK4XQFVfGqmM4Dy_zQT0oLUwPXRCAcs8d4LPEfm7a-OYUnR9-x79m4nfLYX2oK3N2tqDtvagjf8AIBZd7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation</title><source>PubMed Central</source><creator>Besford, Megan ; Leahy, Thomas P ; Sammon, Cormac ; Ulvestad, Maria ; Carroll, Robert ; Mehmud, Faisal ; Alikhan, Raza ; Ramagopalan, Sreeram</creator><creatorcontrib>Besford, Megan ; Leahy, Thomas P ; Sammon, Cormac ; Ulvestad, Maria ; Carroll, Robert ; Mehmud, Faisal ; Alikhan, Raza ; Ramagopalan, Sreeram</creatorcontrib><identifier>ISSN: 1479-6678</identifier><identifier>EISSN: 1744-8298</identifier><identifier>DOI: 10.2217/fca-2020-0175</identifier><language>eng</language><ispartof>Future cardiology, 2021-08, Vol.17 (5), p.855-864</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c152t-e103827c1340ca2c5ceb9407bf6018f5a78a633202260f0996af0b680240c3e63</citedby><cites>FETCH-LOGICAL-c152t-e103827c1340ca2c5ceb9407bf6018f5a78a633202260f0996af0b680240c3e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids></links><search><creatorcontrib>Besford, Megan</creatorcontrib><creatorcontrib>Leahy, Thomas P</creatorcontrib><creatorcontrib>Sammon, Cormac</creatorcontrib><creatorcontrib>Ulvestad, Maria</creatorcontrib><creatorcontrib>Carroll, Robert</creatorcontrib><creatorcontrib>Mehmud, Faisal</creatorcontrib><creatorcontrib>Alikhan, Raza</creatorcontrib><creatorcontrib>Ramagopalan, Sreeram</creatorcontrib><title>CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation</title><title>Future cardiology</title><issn>1479-6678</issn><issn>1744-8298</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkE1LxDAQhoMouK4evecPRCdJm49j3Q8rLKxY9VrSbLpEYytJRf33ZtXLzPDOw8A8CF1SuGKMyuveGsKAAQEqyyM0o7IoiGJaHee5kJoIIdUpOkvpBYBLTfUMfS3qCjO8bHIhz1VjsRl2uK4acrNZLfGDT6-4sWN06XcRnQnkc4xhh7fRBFwNk7ej2X8EM0z4PmM2-s4Pe7x01ic_Dgn7AVdT9Jle-y76EMyU83N00puQ3MV_n6On9epxUZPN9vZuUW2IpSWbiKPAFZOW8gKsYba0rtMFyK4XQFVfGqmM4Dy_zQT0oLUwPXRCAcs8d4LPEfm7a-OYUnR9-x79m4nfLYX2oK3N2tqDtvagjf8AIBZd7A</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Besford, Megan</creator><creator>Leahy, Thomas P</creator><creator>Sammon, Cormac</creator><creator>Ulvestad, Maria</creator><creator>Carroll, Robert</creator><creator>Mehmud, Faisal</creator><creator>Alikhan, Raza</creator><creator>Ramagopalan, Sreeram</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202108</creationdate><title>CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation</title><author>Besford, Megan ; Leahy, Thomas P ; Sammon, Cormac ; Ulvestad, Maria ; Carroll, Robert ; Mehmud, Faisal ; Alikhan, Raza ; Ramagopalan, Sreeram</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c152t-e103827c1340ca2c5ceb9407bf6018f5a78a633202260f0996af0b680240c3e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Besford, Megan</creatorcontrib><creatorcontrib>Leahy, Thomas P</creatorcontrib><creatorcontrib>Sammon, Cormac</creatorcontrib><creatorcontrib>Ulvestad, Maria</creatorcontrib><creatorcontrib>Carroll, Robert</creatorcontrib><creatorcontrib>Mehmud, Faisal</creatorcontrib><creatorcontrib>Alikhan, Raza</creatorcontrib><creatorcontrib>Ramagopalan, Sreeram</creatorcontrib><collection>CrossRef</collection><jtitle>Future cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Besford, Megan</au><au>Leahy, Thomas P</au><au>Sammon, Cormac</au><au>Ulvestad, Maria</au><au>Carroll, Robert</au><au>Mehmud, Faisal</au><au>Alikhan, Raza</au><au>Ramagopalan, Sreeram</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation</atitle><jtitle>Future cardiology</jtitle><date>2021-08</date><risdate>2021</risdate><volume>17</volume><issue>5</issue><spage>855</spage><epage>864</epage><pages>855-864</pages><issn>1479-6678</issn><eissn>1744-8298</eissn><doi>10.2217/fca-2020-0175</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1479-6678
ispartof Future cardiology, 2021-08, Vol.17 (5), p.855-864
issn 1479-6678
1744-8298
language eng
recordid cdi_crossref_primary_10_2217_fca_2020_0175
source PubMed Central
title CHA 2 DS 2 -VASc and HAS-BLED Risk Scores and real-world Oral Anticoagulant Prescribing Decisions in Atrial Fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T13%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CHA%202%20DS%202%20-VASc%20and%20HAS-BLED%20Risk%20Scores%20and%20real-world%20Oral%20Anticoagulant%20Prescribing%20Decisions%20in%20Atrial%20Fibrillation&rft.jtitle=Future%20cardiology&rft.au=Besford,%20Megan&rft.date=2021-08&rft.volume=17&rft.issue=5&rft.spage=855&rft.epage=864&rft.pages=855-864&rft.issn=1479-6678&rft.eissn=1744-8298&rft_id=info:doi/10.2217/fca-2020-0175&rft_dat=%3Ccrossref%3E10_2217_fca_2020_0175%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true